Witty
Sir Andrew Witty announces decision to step down as CEO of GSK
March 17, 2016Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down
Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …
Generics continue to erode GSK sales
May 6, 2015Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory
GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …
GSK picks Singapore for Asian hub
March 12, 2015Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets
Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …
GSK blames respiratory woes as sales drop
February 5, 2015Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales
GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …
EFPIA gives president role to Novartis chief executive
December 10, 2014Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …
GSK fined, executives face jail sentence in Chinese bribery case
September 19, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery, sex tape
China has fined Britain’s largest pharma firm GlaxoSmithKline $490 million (£297m) for corruption after a year-long investigation into claims it …
Another major drop in sales for GSK
July 23, 2014Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …
GSK investigator charged in China
July 14, 2014Medical Communications, Sales and Marketing China, GSK, Witty, bribery, humphrey, sex tape
The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …
GSK China sex tape ‘sent to Witty’
June 30, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape
GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …
Authorities visit Roche China offices
May 23, 2014Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic
A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …
GSK sees profit fall
May 1, 2014Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty
GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …
GSK bribery controversy spreads to Poland
April 14, 2014Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq
Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …
GSK China rep speaks out over ‘bribery culture’
April 2, 2014Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales
A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …
GSK’s Witty loses bonus over China scandal
February 28, 2014Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
